Providing for consideration of the bill (H.R. 5515) to authorize appropriations for fiscal year 2019 for military activities of the Department of Defense and for military construction, to prescribe military personnel strengths for such fiscal year, and for other purposes; providing for consideration of the bill (S. 204) to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes; and providing for consideration of the bill (S. 2155) to promote economic growth, provide tailored regulatory relief, and enhance consumer protections, and for other purposes

Providing for consideration of the bill (H.R. 5515) to authorize appropriations for fiscal year 2019 for military activities of the Department of Defense and for military construction, to prescribe military personnel strengths for such fiscal year, and for other purposes; providing for consideration of the bill (S. 204) to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes; and providing for consideration of the bill (S. 2155) to promote economic growth, provide tailored regulatory relief, and enhance consumer protections, and for other purposes report (to accompany H. Res. 905) United States Congress. House. Committee on Rules, creator text Legislative materials. dcu 2018 monographic eng 1 online resource (73 pages). "May 21, 2018." CRDP Program record. n-us--- United States. Congress. House Rules and practice United States. Department of Defense Appropriations and expenditures United States Armed Forces Military construction operations Law and legislation KF32 .R8 2018z Y 1.1/8:115-698 Y 1.1/8:115-698 Providing for consideration of the bill (H.R. 5515) to authorize appropriations for fiscal year 2019 for military activities of the Department of Defense and for military construction, to prescribe military personnel strengths for such fiscal year, and for other purposes; providing for consideration of the bill (S. 204) to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes; and providing for consideration of the bill (S. 2155) to promote economic growth, provide tailored regulatory relief, and enhance consumer protections, and for other purposes United States. Congress. House. Committee on Rules. (OCoLC)1038274636 Report ; 115-698 United States. Congress. House. https://purl.fdlp.gov/GPO/gpo92851 https://purl.fdlp.gov/GPO/gpo92852 https://purl.fdlp.gov/GPO/gpo92851 https://purl.fdlp.gov/GPO/gpo92852 PUCPR 180601 20180730131845.0 on1038274085 eng